News

Oct 2023   Researchers have now demonstrated that cord blood is still viable after nearly three decades in cryogenic storage.

Oct 2023   A young patient "Xiao An" in China became sick with Aplastic Anemia. Luckily, the parents had stored the cord blood at birth. After 19 years in cryo-storage, the cord blood was thawed and returned to Xiao An. The patient is now in good health, and a new record for long-term self-use of cord blood has been established.

Oct 2023   When young blood is given to old mice it temporarily reverses some symptoms of aging. Researchers are now exploring anti-aging treatments in humans where plasma from young donors is given to older people. The youngest human source of plasma is cord blood. The plasma in cord blood is normally discarded during the cord blood banking process. This is a new opportunity for cord blood banks, but one which must be approached carefully.

Oct 2023   Hemafund cord blood bank of Kyiv, Ukraine, has now opened Hemafund Europe, based in Germany.

Sep 2023   During the first two years of the Coronavirus pandemic, 30 countries registered clinical trials of advanced cell therapy to treat COVID-19. At least 76% of these trials used allogeneic cells. Almost all cells were sourced from a biobank near the hospital treating the COVID-19 patients. Therefore, local biobanks have high value during a pandemic. 

Sep 2023   Some of the largest family cord blood banks have consolidated into networks that have inventory of over a million samples. Yet, family banking is also distributed. There are 97 countries around the world that are served by family bank brands, and 72% of family cord blood companies only have one laboratory.

Aug 2023   A child that underwent a prolonged cardiac arrest was resuscitated, but remained in a persistent vegetative state. After an infusion of his own cord blood, he experienced a remarkable recovery over the next three years that is beyond what can be explained by intense rehabilitation alone. 

Aug 2023   Cord blood transplants will continue to be the best option to cure children with inherited hemoglobin diseases for the foreseeable future. Although gene therapy shows great promise, it is currently much more expensive than stem cell transplants and there are many open questions about how patient outcomes compare. The Lancet Haematology Commission recommends that developing nations which are home to many patients with Sickle Cell Anaemia should expand their capacity for stem cell transplants.

Jul 2023   Matt Farrow received the world's first cord blood transplant in 1988. Matt is now age 40 and shared with us how it feels to be one of the oldest survivors of Fanconi Anemia.    

Jul 2023   Global Cord Blood Corp. is the world's largest cord blood bank, with inventory over one million cord blood units. Yet the company is being liquidated. Why? How did this happen? We explain.